DeutschNewstral
Article
jdsupra.com on 2021-04-15 20:02
Genentech and Centus Notify Court of Settlement of Bevacizumab Litigation
Related news
- Genentech and Centus Settle Bevacizumab Litigationjdsupra.com
- Genentech Sues Centus Over Proposed Bevacizumab Biosimilarjdsupra.com
- Genentech Seeks to Dismiss and Strike Amgen’s Counterclaims and Certain Defenses in Bevacizumab Biosimilar Litigationjdsupra.com
- Genentech and Tanvex Reach Settlement in Principle in Trastuzumab BPCIA Litigationjdsupra.com
- Genentech BPCIA Trastuzumab Case Against Tanvez Dismissed After Settlementjdsupra.com
- Genentech to Move to Dismiss Amgen DJ Complaint Regarding Mvasi (Bevacizumab-AWWB)jdsupra.com
- District Court of Delaware Construes “Following Fermentation” in Genentech v. Amgen Trastuzumab and Bevacizumab Casesjdsupra.com
- Settlement Between Delaware and 30 States Ends MoneyGram Litigationjdsupra.com
- Genentech and Dr. Reddy’s Settle BPCIA Rituximab Litigationjdsupra.com
- Genentech and Biogen File Joint Stipulation of Dismissal in BPCIA Litigation Regarding Tocilizumabjdsupra.com
- Genentech and Dr. Reddy’s Settle BPCIA Litigation Against Proposed Rituxan Biosimilar DRL_RIjdsupra.com
- Bevacizumab Updatesjdsupra.com
- Pay Bias Litigation Results in Costly Settlementjdsupra.com
Settlement is better than litigation, says Judgetribuneonlineng.com- Footlong Litigation to Continue, Despite Settlement Dismissaljdsupra.com
- Proposed Settlement in Target Data Breach Litigationjdsupra.com
Genentech nears trade secrets suit settlement with Taiwanese company but still targeting former employeesbizjournals.com- HUMIRA® Biosimilar Update -- Settlement in AbbVie v. Amgen Case Announced and AbbVie v. Boehringer Ingelheim Litigation Beginsjdsupra.com
- Amgen Files DJ Complaint Against Genentech Regarding Mvasi® (bevacizumab-awwb)jdsupra.com
- Trastuzumab, Rituximab, and Bevacizumab Litigation Updatesjdsupra.com